Bullfrog AI Holdings, Inc. (NASDAQ:BFRG – Get Free Report) CEO Vininder Singh sold 27,958 shares of the business’s stock in a transaction dated Thursday, April 3rd. The stock was sold at an average price of $1.44, for a total value of $40,259.52. Following the transaction, the chief executive officer now owns 2,348,341 shares in the company, valued at approximately $3,381,611.04. This represents a 1.18 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Vininder Singh also recently made the following trade(s):
- On Tuesday, April 1st, Vininder Singh sold 7,245 shares of Bullfrog AI stock. The shares were sold at an average price of $1.61, for a total value of $11,664.45.
Bullfrog AI Stock Down 7.8 %
NASDAQ BFRG opened at $1.30 on Friday. Bullfrog AI Holdings, Inc. has a fifty-two week low of $1.23 and a fifty-two week high of $4.84. The business has a 50 day moving average price of $2.28 and a two-hundred day moving average price of $2.34. The stock has a market cap of $12.24 million, a PE ratio of -1.53 and a beta of 0.33.
Institutional Trading of Bullfrog AI
Large investors have recently modified their holdings of the business. Raymond James Financial Inc. acquired a new position in shares of Bullfrog AI in the fourth quarter worth about $30,000. Two Sigma Securities LLC purchased a new stake in Bullfrog AI during the 4th quarter worth approximately $41,000. Finally, Geode Capital Management LLC raised its position in shares of Bullfrog AI by 31.0% in the 4th quarter. Geode Capital Management LLC now owns 47,093 shares of the company’s stock valued at $94,000 after purchasing an additional 11,140 shares in the last quarter. 0.96% of the stock is currently owned by institutional investors and hedge funds.
Bullfrog AI Company Profile
Bullfrog AI Holdings, Inc, through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data.
Featured Stories
- Five stocks we like better than Bullfrog AI
- How to Choose Top Rated Stocks
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- What is a support level?
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- 3 Small Caps With Big Return Potential
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Receive News & Ratings for Bullfrog AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bullfrog AI and related companies with MarketBeat.com's FREE daily email newsletter.